GARDASIL Reexamination Study (V501-059)

Clinical trial NCT01062074 · COMPLETED

Trial details

NCT number: NCT01062074
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Human Papillomavirus (HPV) Infection

Start date: 2007-09-28
Primary completion: 2013-05-07
Enrollment: 3605

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.